2,6-Diaminopurine is a purine nucleoside analogue. The finished product is a pure white crystalline solid. After multiple purification steps, its purity is consistently above 99.6%, with extremely low levels of hydrolysis impurities and heavy metal residues. The physicochemical properties are consistent across batches, and experimental repeatability is excellent. This substance has a structure highly similar to natural adenine, allowing it to infiltrate the cellular nucleic acid synthesis chain and interfere with DNA and RNA replication processes. It also possesses dual antiviral and antiproliferative effects, with minimal background interference in cellular experiments.
🧬 Spatial configuration of diaminopurine
2,6-Diaminopurine has the complete molecular formula C₅H₆N₆ and a relative molecular mass of 150.15. Its purine core, with its six-membered and five-membered rings fused together, forms a regular planar structure. The molecule contains no chiral carbon atoms, eliminating stereoisomers that could interfere with detection data. Its overall planar configuration allows for perfect insertion into the base-pairing regions of double-stranded nucleic acids, which is the core structural basis for its ability to mimic natural adenine and interfere with nucleic acid synthesis. Ordinary purine derivatives have disordered side chain groups, making it difficult to fit into DNA base grooves and easily recognized and rejected by nucleic acid polymerases. This product, however, has amino groups only at positions 2 and 6, and its overall spatial dimensions are almost identical to those of natural adenine. Polymerases cannot distinguish between the two, making it highly susceptible to accidental incorporation into nascent nucleic acid chains.
The purine core is the core backbone for base pairing. The nitrogen atoms within the ring can form a stable hydrogen bond network, pairing with thymine and uracil. Natural adenine has an amino group only at position 6. This product adds an additional amino group at position 2, increasing the number of hydrogen bond binding sites. When incorporated into the nucleic acid chain, it alters the hydrogen bond arrangement within the double helix, disrupting the original stable double-helix structure of the nucleic acid. This causes the DNA and RNA chains to become distorted, hindering subsequent replication and transcription. Simply put, the extra amino group changes the balance of base pairing, directly disrupting the normal metabolic process of nucleic acids.
The free amino groups at positions 2 and 6 are key functional groups. They can form hydrophilic adsorption forces with the catalytic pocket of nucleic acid polymerases, increasing the efficiency of molecule uptake and incorporation into nucleic acids. They can also bind to cellular nucleoside kinases, rapidly converting them into their triphosphate active form. Purine molecules without amino modification cannot be activated by cellular kinase phosphate and lack biological activity after entering the cell. The dual-amino structure significantly improves molecular activation efficiency, significantly inhibiting nucleic acid replication even at low concentrations, with an experimentally effective concentration lower, making it suitable for high-throughput drug screening.
2,6-Diaminopurine has moderate overall lipid-water balance and is soluble in water, PBS buffer, and complete cell culture medium at room temperature. It does not precipitate or separate into layers when preparing gradient working solutions. Large molecular weight nucleic acid inhibitors struggle to cross cell and nuclear membranes and reach nucleic acid synthesis sites. This product, with its small molecular weight and moderate polarity, can freely penetrate cell membranes and nuclear pores, rapidly entering the cell nucleus to participate in nucleic acid synthesis reactions. It functions stably in animal cells, virus-infected cells, and microbial strains.
⚙️ Interferes with nucleic acid replication process
In normal cells, adenine undergoes phosphorylation activation according to a fixed process, participating in DNA replication and RNA transcription. Base pairing rules are fixed, the double-stranded structure of nucleic acids is stable, and cell division and viral proliferation rely on an ordered nucleic acid synthesis cycle. Human cells, normal microorganisms, and uninfected host cells possess a complete nucleic acid repair mechanism. Base substitutions and strand damage are rapidly identified and repaired, maintaining genome stability and a stable and controllable cell proliferation rhythm, preventing growth arrest and apoptosis.
When cells come into contact with 2,6-Diaminopurine, the molecule is phosphorylated by nucleoside kinases, converting it into diphosphate and triphosphate active derivatives. These derivatives compete with natural adenine triphosphate for binding to nucleic acid polymerases. The polymerases cannot distinguish between the two purine structures and continuously incorporate 2,6-Diaminopurine triphosphate into nascent DNA and RNA chains, gradually replacing the original normal adenine bases and disrupting the base composition of the nucleic acid chains.
The 2,6-Diaminopurine incorporated into the nucleic acid chain, with its diamino structure, alters the number of hydrogen bonds and steric tension in the double helix, causing distortion of the nucleic acid double helix structure. Nucleic acid helicases and repair enzymes cannot properly recognize the damage sites, rendering the cell's own repair mechanisms ineffective. The distorted nucleic acid chain cannot complete replication and transcription, interrupting the supply of raw materials for downstream protein synthesis. Cell division is arrested at the synthesis stage, and viral genome replication is simultaneously interrupted, achieving the dual effect of inhibiting cell proliferation and blocking viral amplification.
The continuous accumulation of abnormal nucleic acid chains activates the cellular DNA damage stress pathway, upregulates the expression of apoptosis-related proteins, and induces programmed apoptosis in abnormally proliferating cells and virus-infected host cells. Compared to broad-spectrum nucleic acid toxic agents that indiscriminately kill all cells, this product only shows significant effects on rapidly dividing and rapidly replicating nucleic acids. Normal cells with slow-proliferating cells show low uptake and minimal damage. Experiments can precisely target the single variable of inhibited nucleic acid synthesis, reducing data interference from irrelevant apoptosis.
2,6-Diaminopurine exhibits broad-spectrum inhibitory effects against various DNA and RNA viruses. Viruses lack a complete nucleic acid repair system; upon incorporation of abnormal purines, their genome directly loses its replication ability, and progeny viruses cannot assemble and mature for release. Normal host cells, on the other hand, have a well-developed repair system; even at low concentrations, they only show a temporary slowdown in proliferation without widespread cell death. In antiviral mechanism studies, this clearly distinguishes the differentiated responses between host cells and viruses, resulting in more identifiable experimental results.
🧫 Multi-directional nucleic acid research applications
2,6-Diaminopurine is a standard positive control for nucleic acid metabolism pathway research, primarily used in the construction of in vitro models of tumor cell proliferation. Tumor cells divide rapidly and have vigorous nucleic acid synthesis metabolism, leading to the uptake of large amounts of purine precursors. This product, when incorporated into the nucleic acid chains of tumor cells, blocks replication and is commonly used in experiments detecting cell colony formation, cell cycle, and apoptosis. It is also used to compare the activity of various novel nucleoside-based antiproliferative molecules and to establish standardized experimental systems for tumor nucleic acid metabolism intervention.
2,6-Diaminopurine is widely used in in vitro antiviral mechanism research, suitable for experiments with various strains such as herpesvirus, poxvirus, and RNA influenza virus. Viral replication relies entirely on the host's nucleic acid synthesis system. This product, when incorporated into the viral genome, directly blocks the generation of progeny viruses. Researchers use it to detect changes in viral titer and viral protein expression levels, identify key steps in viral nucleic acid replication, and screen small molecule compounds with antiviral potential. It is a staple tool in viral pharmacology laboratories.
It has wide applications in the field of microbial genetics and breeding, and can be used for the screening and modification of bacterial and fungal strains. Microorganisms have weak nucleic acid repair capabilities, and the incorporation of 2,6-Diaminopurine easily induces gene mutations. Researchers utilize this characteristic to induce bacterial mutations, screen for engineered strains that produce high levels of metabolites and are resistant to stress, and simultaneously explore microbial purine metabolism regulatory pathways to improve experimental protocols for microbial genetic modification.
All novel nucleoside antiviral and antitumor lead molecules are developed using 2,6-Diaminopurine as a standardized efficacy reference. Various modified purine and pyrimidine derivatives and nucleoside prodrugs require cross-sectional comparisons of nucleic acid incorporation efficiency, cell proliferation inhibition activity, viral blocking ability, and cytotoxicity. 2,6-Diaminopurine exhibits stable efficacy and strong data reproducibility, making it a universally applicable standard for initial screening, structure-activity relationship analysis, and molecular structure optimization of nucleoside drugs.
2,6-Diaminopurine can also be used to explore gene damage and cell repair mechanisms, and to construct in vitro cell models of DNA damage. Continuous incubation at low concentrations of this product can stably induce genomic base substitution damage, simulating the pathological state of endogenous and exogenous nucleic acid damage. Researchers can use this model to explore the functions of DNA repair-related genes, screen for active molecules that enhance cell repair capabilities and strengthen tumor DNA damage, and improve the research system related to genomic stability.
🔬 Molecular Improvement and Optimization Directions
Site-specific modification of the purine ring is currently the mainstream optimization approach, with modification sites concentrated on the amino groups at positions 2 and 6. The original molecule lacks cell-targeting ability, is uniformly taken up by cells throughout the body, and requires high concentrations to inhibit the proliferation of lesion cells. By grafting tumor- and virus-infected cell-specific affinity fragments onto the amino sites, the modified derivatives can be directionally enriched in diseased cells undergoing rapid nucleic acid synthesis, achieving nucleic acid blocking effects at lower doses while reducing the slight growth inhibition caused by normal cell uptake, making it suitable for the development of low-concentration, long-acting intervention cell models.
Microenvironment-responsive prodrug modification is a popular optimization route in recent years, addressing the shortcoming of indiscriminate molecule entry into cells. The research team has added a breakable masking group to the dual amino sites to construct a lesion-specific activation prodrug. Unactivated molecules cannot be phosphorylated by nucleoside kinases and do not interfere with normal cellular nucleic acid metabolism; only in the specific microenvironment of tumor and virus-infected cells, the masking group breaks to release active 2,6-Diaminopurine, precisely blocking nucleic acid synthesis in diseased cells, further enhancing the specificity of action.
Hybrid molecule splicing expands the boundaries of pharmacological action, overcoming the limitations of single nucleic acid blocking functions. Tumors and viral infections are accompanied by disruptions in multiple pathways, including inflammation and oxidative stress. Simply blocking nucleic acid synthesis is insufficient to completely eradicate diseased cells. Researchers covalently spliced the purine core of this product with antioxidant and immunomodulatory active fragments to create a multifunctional hybrid molecule. This molecule simultaneously achieves a triple effect of blocking nucleic acid replication, alleviating oxidative damage, and enhancing immune clearance, providing a new approach for designing complex antiviral and antitumor lead molecules.
Ring substitution fine-tunes the base pairing strength to adapt to different experimental needs. The original molecule exhibits balanced inhibition of DNA and RNA synthesis, while viruses primarily rely on RNA replication, and solid tumors are mainly characterized by abnormal DNA replication. By modifying the purine ring carbon sites with methyl and fluorine substitutions, the molecule's affinity for DNA and RNA polymerases can be precisely adjusted, creating biased derivatives specifically tailored to two different research scenarios: viral experiments and tumor cell experiments.
Conclusion
2,6-Diaminopurine is an irreplaceable "molecular hub" in the synthesis of purine nucleoside analog drugs. Its C2 amino group modification endows it with the potential to be converted into an active guanine nucleoside analog under ADA catalysis, making it a key building block in the synthesis of blockbuster drugs such as cladribine, nelabine, and abacavir. Simultaneously, as a base modification unit in oligonucleotide drugs, it is playing an increasingly important role in the field of nucleic acid therapy by enhancing target binding affinity and enzyme stability.
Are you ready to find out how our 2,6-Diaminopurine will improve your product line? Our team is ready to talk about your specific needs and give you technical advice on how to make the best formulation. Email us at allen@faithfulbio.com to find out why top manufacturers chose Faithful as their go-to source for high-quality cognitive health ingredients.
References
- National Center for Biotechnology Information. (2026). 2,6-Diaminopurine (PubChem CID 30976).
- EMBL-EBI. (n.d.). 9H-purine-2,6-diamine (CHEBI:40235). ChEBI.
- National Institute of Standards and Technology. (n.d.). 2,6-Diaminopurine (NIST Chemistry WebBook).
- Rivela, C., et al. (2023). Biotransformation of 2,6-diaminopurine nucleosides by immobilized Geobacillus stearothermophilus. CONICET Digital.
- (2006). Microbial synthesis of 2,6-diaminopurine nucleosides. Journal of Molecular Catalysis B: Enzymatic.
- Ross, B. S., et al. (2008). An efficient and scalable synthesis of 2,6-diaminopurine riboside. Nucleosides, Nucleotides & Nucleic Acids.